Cargando…

Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology

Atherosclerosis is a common metabolic disease characterized by lipid metabolic disorder. The processes of atherosclerosis include endothelial dysfunction, new endothelial layer formation, lipid sediment, foam cell formation, plaque formation, and plaque burst. Owing to the adverse effects of first-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xuejiao, Ma, Xingyu, Zeng, Siyu, Tang, Wansi, Xiao, Liucheng, Zhu, Chenggong, Yu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106879/
https://www.ncbi.nlm.nih.gov/pubmed/32256641
http://dx.doi.org/10.1155/2020/3568756
_version_ 1783512707931045888
author Xie, Xuejiao
Ma, Xingyu
Zeng, Siyu
Tang, Wansi
Xiao, Liucheng
Zhu, Chenggong
Yu, Rong
author_facet Xie, Xuejiao
Ma, Xingyu
Zeng, Siyu
Tang, Wansi
Xiao, Liucheng
Zhu, Chenggong
Yu, Rong
author_sort Xie, Xuejiao
collection PubMed
description Atherosclerosis is a common metabolic disease characterized by lipid metabolic disorder. The processes of atherosclerosis include endothelial dysfunction, new endothelial layer formation, lipid sediment, foam cell formation, plaque formation, and plaque burst. Owing to the adverse effects of first-line medications, it is urgent to discover new medications to deal with atherosclerosis. Berberine is one of the most promising natural products derived from traditional Chinese medicine. However, the panoramic mechanism of berberine against atherosclerosis has not been discovered clearly. In this study, we used network pharmacology to investigate the interaction between berberine and atherosclerosis. We identified potential targets related to berberine and atherosclerosis from several databases. A total of 31 and 331 putative targets for berberine and atherosclerosis were identified, respectively. Then, we constructed berberine and atherosclerosis targets with PPI data. Berberine targets network with PPI data had 3204 nodes and 79437 edges. Atherosclerosis targets network with PPI data had 5451 nodes and 130891 edges. Furthermore, we merged the two PPI networks and obtained the core PPI network from the merged PPI network. The core PPI network had 132 nodes and 3339 edges. At last, we performed functional enrichment analyses including GO and KEGG pathway analysis in David database. GO analysis indicated that the biological processes were correlated with G1/S transition of mitotic cells cycle. KEGG pathway analysis found that the pathways directly associated with berberine against atherosclerosis were cell cycle, ubiquitin mediated proteolysis, MAPK signaling pathway, and PI3K-Akt signaling pathway. After combining the results in context with the available treatments for atherosclerosis, we considered that berberine inhibited inflammation and cell proliferation in the treatment of atherosclerosis. Our study provided a valid theoretical foundation for future research.
format Online
Article
Text
id pubmed-7106879
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71068792020-04-03 Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology Xie, Xuejiao Ma, Xingyu Zeng, Siyu Tang, Wansi Xiao, Liucheng Zhu, Chenggong Yu, Rong Evid Based Complement Alternat Med Research Article Atherosclerosis is a common metabolic disease characterized by lipid metabolic disorder. The processes of atherosclerosis include endothelial dysfunction, new endothelial layer formation, lipid sediment, foam cell formation, plaque formation, and plaque burst. Owing to the adverse effects of first-line medications, it is urgent to discover new medications to deal with atherosclerosis. Berberine is one of the most promising natural products derived from traditional Chinese medicine. However, the panoramic mechanism of berberine against atherosclerosis has not been discovered clearly. In this study, we used network pharmacology to investigate the interaction between berberine and atherosclerosis. We identified potential targets related to berberine and atherosclerosis from several databases. A total of 31 and 331 putative targets for berberine and atherosclerosis were identified, respectively. Then, we constructed berberine and atherosclerosis targets with PPI data. Berberine targets network with PPI data had 3204 nodes and 79437 edges. Atherosclerosis targets network with PPI data had 5451 nodes and 130891 edges. Furthermore, we merged the two PPI networks and obtained the core PPI network from the merged PPI network. The core PPI network had 132 nodes and 3339 edges. At last, we performed functional enrichment analyses including GO and KEGG pathway analysis in David database. GO analysis indicated that the biological processes were correlated with G1/S transition of mitotic cells cycle. KEGG pathway analysis found that the pathways directly associated with berberine against atherosclerosis were cell cycle, ubiquitin mediated proteolysis, MAPK signaling pathway, and PI3K-Akt signaling pathway. After combining the results in context with the available treatments for atherosclerosis, we considered that berberine inhibited inflammation and cell proliferation in the treatment of atherosclerosis. Our study provided a valid theoretical foundation for future research. Hindawi 2020-03-19 /pmc/articles/PMC7106879/ /pubmed/32256641 http://dx.doi.org/10.1155/2020/3568756 Text en Copyright © 2020 Xuejiao Xie et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xie, Xuejiao
Ma, Xingyu
Zeng, Siyu
Tang, Wansi
Xiao, Liucheng
Zhu, Chenggong
Yu, Rong
Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
title Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
title_full Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
title_fullStr Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
title_full_unstemmed Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
title_short Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
title_sort mechanisms of berberine for the treatment of atherosclerosis based on network pharmacology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106879/
https://www.ncbi.nlm.nih.gov/pubmed/32256641
http://dx.doi.org/10.1155/2020/3568756
work_keys_str_mv AT xiexuejiao mechanismsofberberineforthetreatmentofatherosclerosisbasedonnetworkpharmacology
AT maxingyu mechanismsofberberineforthetreatmentofatherosclerosisbasedonnetworkpharmacology
AT zengsiyu mechanismsofberberineforthetreatmentofatherosclerosisbasedonnetworkpharmacology
AT tangwansi mechanismsofberberineforthetreatmentofatherosclerosisbasedonnetworkpharmacology
AT xiaoliucheng mechanismsofberberineforthetreatmentofatherosclerosisbasedonnetworkpharmacology
AT zhuchenggong mechanismsofberberineforthetreatmentofatherosclerosisbasedonnetworkpharmacology
AT yurong mechanismsofberberineforthetreatmentofatherosclerosisbasedonnetworkpharmacology